H7N9 influenza A virus split vaccine (shanghai institute of biological products)

甲型H7N9流感病毒裂解疫苗（上海生物制品研究所）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameH7N9 influenza A virus split vaccine (shanghai institute of biological products)

Drug Alias NameN/A

ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Split vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsInfluenza A virus infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesShanghai Institute of Biological Products Co Ltd

China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesShanghai Institute of Biological Products Co Ltd

Inactive CompaniesN/A

Active IndicationsInfluenza A virus infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A